Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2012
10/09/2012US8283138 Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins
10/09/2012US8283117 Disease diagnosis method, marker screening method and marker using TOF-SIMS
10/09/2012US8282990 Method for preparing a biodegradable polymer microsphere containing a glucose-regulating peptide
10/09/2012US8282964 Ex-vivo treatment of peripheral plasmacytoid dendritic cells with IFN-lambda
10/09/2012US8282963 Methods for extracting platelets and compositions obtained therefrom
10/09/2012US8282944 Metal complexes incorporated within biodegradable nanoparticles and their use
10/09/2012US8282934 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
10/09/2012US8282931 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
10/09/2012US8282925 Method for treating rheumatoid arthritis using anti-S100A9 antibody
10/09/2012US8282921 tRNA synthetase fragments
10/09/2012US8282914 Method for treating atherosclerosis by administering human MCP1 fusions
10/09/2012CA2710965C Growing renal tubule cells and ex vivo renal tubule tissue system
10/09/2012CA2674542C Neuroprotection by blood flow stabilization
10/09/2012CA2634902C Anticancer agent comprising a peptide
10/09/2012CA2633516C Elongase genes and uses thereof
10/09/2012CA2507835C Sustained improver of muscular fatigue
10/09/2012CA2466474C Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses
10/09/2012CA2458806C Antisense oligonucleotide against human ache and uses thereof
10/09/2012CA2455830C Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
10/09/2012CA2403501C Non-invasive gene targeting to the brain
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/09/2012CA2323751C Diagnostics and vaccines for mycobacterial infections of animals and humans
10/09/2012CA2243845C Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
10/09/2012CA2229204C Deubiquitinating enzymes that regulate cell growth
10/09/2012CA2164698C Synthetic peptide inhibitors of hiv transmission
10/04/2012WO2012135868A2 Compositions and methods for the treatment and prevention of cardiac ischemic injury
10/04/2012WO2012135846A1 Methods of eradicating bacterial cell populations
10/04/2012WO2012135818A2 Cancer diagnostics, therapeutics, and drug discovery associated with macropinocytosis
10/04/2012WO2012135729A2 Methods and compositions for targeting adipose cells in mammals
10/04/2012WO2012135695A2 Modulation of cellular migration
10/04/2012WO2012135666A1 Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications
10/04/2012WO2012135646A2 Proteases for degrading gluten
10/04/2012WO2012135636A1 Lantibiotic nai-802, pharmaceutically acceptable salts, compositions, and uses thereof
10/04/2012WO2012135630A2 Crk-a novel target for cancer therapy
10/04/2012WO2012135624A1 Treatment of colon cancer using complement inhibitors
10/04/2012WO2012135598A2 Use of il-17d for the treatment and prevention of cancers
10/04/2012WO2012135575A2 Compositions and methods for introduction of macromolecules into cells
10/04/2012WO2012135528A2 Galectin-3c combination therapy for human cancer
10/04/2012WO2012135448A1 Endopeptidase treatment of smooth muscle disorders
10/04/2012WO2012135422A2 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
10/04/2012WO2012135385A1 Methods and compositions related to inhibition of viral entry
10/04/2012WO2012135343A1 Endopeptidase treatment of sexual dysfunction disorders
10/04/2012WO2012135304A1 Vagal nerve-based disorders
10/04/2012WO2012135230A2 Compositions and methods to modulate hair growth
10/04/2012WO2012135177A2 Methods and compositions for cytomegalovirus il-10 protein
10/04/2012WO2012135176A2 The use of wnt agents to prevent hypoxic injury
10/04/2012WO2012135046A1 Pegylated human hdl particle and process for production thereof
10/04/2012WO2012135010A2 Osmotic mediated release synthetic nanocarriers
10/04/2012WO2012134989A1 Aureobasidium derivatives and methods of synthesis
10/04/2012WO2012134967A2 Three-dimensional structure of hin1 nucleoprotein in complex with antiviral compounds
10/04/2012WO2012134915A1 Ezatiostat for treating multiple myeloma
10/04/2012WO2012134904A1 Endopeptidase treatment of involuntary movement disorders
10/04/2012WO2012134902A1 Endopeptidase and neurotoxin combination treatment of dystonia, cerebral palsy and migraine
10/04/2012WO2012134901A1 Re-targeted endopeptidases for use in the treatment of skin diseases
10/04/2012WO2012134900A1 Endopeptidase treatment of neuroendocrine disorders
10/04/2012WO2012134897A1 Treatment of sensory disturbance disorders
10/04/2012WO2012134540A2 Injectable synthetic pur composite
10/04/2012WO2012134478A1 Compositions and methods for the treatment and prevention of cardiac ischemic injury
10/04/2012WO2012134332A1 Method for producing a fibrinolytic preparation and use of the latter for treating myocardial infarction
10/04/2012WO2012134240A2 Lyophilized preparation of botulinum toxin
10/04/2012WO2012134234A2 Use of hades as a negative modulator of akt
10/04/2012WO2012133825A1 Hot flash suppressant
10/04/2012WO2012133792A1 Protein-containing composition and method for producing same
10/04/2012WO2012131676A1 Method for treating disorders of the skin
10/04/2012WO2012131477A1 Methods for using semaphorin polypeptides
10/04/2012WO2012131109A2 Peptides and pharmaceutical compositions for use in the treatment by nasal administration of patients suffering from anxiety and sleep disorders
10/04/2012WO2012131061A1 Treatment for infection with hepatitis b virus alone or in combination with hepatitis delta virus and associated liver diseases
10/04/2012WO2012130999A1 Peptides isolated and purified from fruit bat testicles
10/04/2012WO2012130970A1 Natural derivative of the lactobacillus johnsonii strain cncm i-1225 deficient in d-lactic acid production
10/04/2012WO2012130966A1 Derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with an improved shelf life
10/04/2012WO2012130965A1 Natural derivative of a well known and successful probiotic strain deficient in d-lactic acid production
10/04/2012WO2012130955A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
10/04/2012WO2012130866A1 Novel glucagon analogues
10/04/2012WO2012130862A1 Selection of hcv treatment
10/04/2012WO2012130775A1 Pgc-1alpha-modulating peptides
10/04/2012WO2012130771A1 Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
10/04/2012WO2012130193A1 Non-covalent soluble complexes of teriparatide with polysaccharides and a dosage form of teriparatide for oral administration
10/04/2012WO2012130141A1 Method and composition for enhancing target cells uptake of therapeutic agents
10/04/2012WO2012130136A1 Glucagon-like peptide-1 analogue monomer and dimer, preparation method therefor and application thereof
10/04/2012WO2012130015A1 Site-directed mono-substituted pegylated exendin analog and preparation method therefor
10/04/2012WO2012129680A1 Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan
10/04/2012WO2012129671A1 Prodrugs of d-isoglutamyl-[d/l]-tryptophan
10/04/2012WO2012113802A1 Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
10/04/2012WO2012109464A3 Modified peptide that reduces pain in peripheral neuropathy
10/04/2012WO2012106461A9 Combination therapy for treatment of cancer
10/04/2012WO2012104418A3 Method for inactivation/removal of coagulation factors by precipitation
10/04/2012WO2012094495A3 Clip modulation for the treatment of mucosal diseases
10/04/2012WO2012090207A3 Par1 and par2 c-tail peptides and peptide mimetics
10/04/2012WO2012087742A3 Methods and compositions suitable for managing blood glucose in animals
10/04/2012WO2012068464A3 Methods of treating and preventing thrombotic diseases using ask1 inhibitors
10/04/2012WO2012061750A3 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
10/04/2012WO2012061689A3 A new variant of antihemophilic factor viii having increased specific activity
10/04/2012US20120255045 Inducible small rna expression constructs for targeted gene silencing
10/04/2012US20120253298 Layered tissue thickness compensator
10/04/2012US20120253191 Porphyrin nanovesicles
10/04/2012US20120253020 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways
10/04/2012US20120252895 Therapeutic methods employing nitric oxide precursors
10/04/2012US20120252884 Modified and Stabilized GDF Propeptides and Uses Thereof
10/04/2012US20120252869 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
10/04/2012US20120252846 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
1 ... 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 ... 3163